rxstat › Prices in Nova Scotia › Tildrakizumab

Tildrakizumab (Ilumya) price and coverage in Nova Scotia

Tildrakizumab 100 mg/ml solution lists at $4935.00 per billed unit in Nova Scotia on Nova Scotia Pharmacare's price list (Nov 1, 2026), before the pharmacy's dispensing fee.

Tildrakizumab is covered by Nova Scotia Pharmacare only under exception status: your prescriber has to request coverage, and it applies to patients who meet set criteria.

Provinces bill this product in different units (per mL, per pen or per vial), so their prices are not directly comparable.

Price by strength in Nova Scotia

Strength and formLowest priceBrand
100 mg/ml Solution2 products · special approval$4935.00/unit–
All 2 products listed in Nova Scotia
ProductPriceCoverage
100 mg/ml Solution
IlumyaSUN · DIN 02516098$4935.00/unitSpecial approval
IlumyaSUN · DIN 02558904$4935.00/unitSpecial approval

What you'll pay at the pharmacy

These are the prices Nova Scotia Pharmacare lists for the drug itself. The pharmacy adds a dispensing fee and sometimes a markup, so paying cash costs more. If you have coverage, your share depends on your deductible and co-pay.

Shortage status

No active shortage is reported for Tildrakizumab in Canada. Full drug page.

Tildrakizumab price in other provinces

Common questions

How much does Tildrakizumab cost in Nova Scotia?

Tildrakizumab 100 mg/ml solution lists at $4935.00 per billed unit in Nova Scotia on Nova Scotia Pharmacare's price list (Nov 1, 2026), before the pharmacy's dispensing fee.

Is Tildrakizumab covered in Nova Scotia?

Tildrakizumab is covered by Nova Scotia Pharmacare only under exception status: your prescriber has to request coverage, and it applies to patients who meet set criteria.

Is Tildrakizumab cheaper in another province?

For 100 mg/ml solution, listed prices run from $4935.00 to $4935.00 across 3 provinces. Public plans only cover their own residents, though.

Source: Nova Scotia Pharmacare Formulary (Nov 1, 2026). Public plan list prices per unit, before pharmacy fees and markup. This page is not medical advice.